335 related articles for article (PubMed ID: 26453486)
1. Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population.
Karatayli-Ozgursoy S; Bishop JA; Hillel A; Akst L; Best SR
Ann Otol Rhinol Laryngol; 2016 Mar; 125(3):235-41. PubMed ID: 26453486
[TBL] [Abstract][Full Text] [Related]
2. Degrees of dysplasia and the use of cidofovir in patients with recurrent respiratory papillomatosis.
Gupta HT; Robinson RA; Murray RC; Karnell LH; Smith RJ; Hoffman HT
Laryngoscope; 2010 Apr; 120(4):698-702. PubMed ID: 20205173
[TBL] [Abstract][Full Text] [Related]
3. Use of intralesional cidofovir in the recurrent respiratory papillomatosis: a review of the literature.
Gazia F; Galletti B; Freni F; Bruno R; Sireci F; Galletti C; Meduri A; Galletti F
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):956-962. PubMed ID: 32017003
[TBL] [Abstract][Full Text] [Related]
4. Degrees of dysplasia based on viral typing in patients with cidofovir use and recurrent respiratory papillomatosis.
Moore JE; Garcia A; Sanyal S; Saunders S; Portnoy JE; Hu A; Sataloff RT
J Voice; 2013 Nov; 27(6):765-8. PubMed ID: 24128893
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients.
Carvalho CM; Huot L; Charlois AL; Khalfallah SA; Chapuis F; Froehlich P
Acta Otolaryngol; 2009 Apr; 129(4):462-70. PubMed ID: 19235575
[TBL] [Abstract][Full Text] [Related]
6. Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir.
Fusconi M; Grasso M; Greco A; Gallo A; Campo F; Remacle M; Turchetta R; Pagliuca G; DE Vincentiis M
Acta Otorhinolaryngol Ital; 2014 Dec; 34(6):375-81. PubMed ID: 25762828
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of dysplasia in juvenile-onset recurrent respiratory papillomatosis.
Sajan JA; Kerschner JE; Merati AL; Osipov V; Szabo S; Blumin JH
Arch Otolaryngol Head Neck Surg; 2010 Jan; 136(1):7-11. PubMed ID: 20083770
[TBL] [Abstract][Full Text] [Related]
8. Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.
Donne AJ; Rothera MP; Homer JJ
Int J Pediatr Otorhinolaryngol; 2008 Jul; 72(7):939-44. PubMed ID: 18502519
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of microsurgery in combined with topical-PDT in treating recurrent respiratory papillomatosis: compare JORRP with AORRP.
Yang S; Zhou C; Sun B; Wang F; Han Z; Zhang H; Han J; Shen Y; Zhang J
Acta Otolaryngol; 2019 Dec; 139(12):1133-1139. PubMed ID: 31556770
[No Abstract] [Full Text] [Related]
10. Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis.
Graupp M; Gugatschka M; Kiesler K; Reckenzaun E; Hammer G; Friedrich G
Eur Arch Otorhinolaryngol; 2013 Feb; 270(2):641-6. PubMed ID: 23070260
[TBL] [Abstract][Full Text] [Related]
11. Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
Murono S; Nakanishi Y; Tsuji A; Endo K; Kondo S; Wakisaka N; Yoshizaki T
Auris Nasus Larynx; 2016 Oct; 43(5):541-5. PubMed ID: 26860235
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.
Wierzbicka M; Jackowska J; Bartochowska A; Józefiak A; Szyfter W; Kędzia W
Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1305-11. PubMed ID: 21519834
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of human papillomavirus 6 and 11 variants in recurrent respiratory papillomatosis.
Sichero L; Ferreira S; López RVM; Mello BP; Costa V; El-Achkar VNR; Carlos R; Ribeiro-Silva A; Pignatari S; Kaminagakura E; Villa LL
J Med Virol; 2021 Jun; 93(6):3835-3840. PubMed ID: 32910471
[TBL] [Abstract][Full Text] [Related]
14. The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis.
Mikolajczak S; Quante G; Weissenborn S; Wafaisade A; Wieland U; Lüers JC; Klussmann JP; Beutner D
Eur Arch Otorhinolaryngol; 2012 Dec; 269(12):2543-8. PubMed ID: 22766836
[TBL] [Abstract][Full Text] [Related]
15. Juvenile-onset recurrent respiratory papillomatosis with pulmonary involvement and carcinomatous transformation.
Mitsumoto GL; Bernardi FDC; Paes JF; Villa LL; Mello B; Pozzan G
Autops Case Rep; 2018; 8(3):e2018035. PubMed ID: 30101139
[TBL] [Abstract][Full Text] [Related]
16. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.
Shehab N; Sweet BV; Hogikyan ND
Pharmacotherapy; 2005 Jul; 25(7):977-89. PubMed ID: 16006276
[TBL] [Abstract][Full Text] [Related]
17. Molecular transformation of recurrent respiratory papillomatosis: viral typing and p53 overexpression.
Go C; Schwartz MR; Donovan DT
Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):298-302. PubMed ID: 12731623
[TBL] [Abstract][Full Text] [Related]
18. Intralesional injection of cidofovir for recurrent respiratory papillomatosis in children.
Bielecki I; Mniszek J; Cofała M
Int J Pediatr Otorhinolaryngol; 2009 May; 73(5):681-4. PubMed ID: 19193450
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Involvement in Recurrent Respiratory Papillomatosis: A Systematic Review.
Sechi I; Muresu N; Di Lorenzo B; Saderi L; Puci M; Aliberti S; Maida I; Mondoni M; Piana A; Sotgiu G
Infect Dis Rep; 2024 Feb; 16(2):200-215. PubMed ID: 38525763
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical implications of low-risk human papillomavirus among patients with recurrent respiratory papillomatosis in Rio de Janeiro, Brazil.
Figueiredo MC; Justino MC; Delmonico L; Silvestre RT; de Castro TL; Dos Santos Moreira A; Macedo JMB; da Costa Carvalho MDG; Scherrer L; de Medeiros Lima DJM; Alves G; Ornellas MH
Auris Nasus Larynx; 2019 Aug; 46(4):570-575. PubMed ID: 30581074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
